Clinical trials
Lung Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 8 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Recruiting | 16 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Unknown status | 5 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 17 |
| Novartis Pharmaceuticals | 6 |
| Eli Lilly and Company | 5 |
| Pfizer | 5 |
| Bayer | 4 |
| Vertex Pharmaceuticals Incorporated | 4 |
| Aeris Therapeutics | 2 |
| CENTOGENE GmbH Rostock | 2 |
| Hoffmann-La Roche | 2 |
| Klaus Kenn | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 93 |
| Respiratory Tract Diseases | 43 |
| Pulmonary Disease, Chronic Obstructive | 21 |
| Lung Diseases, Obstructive | 18 |
| Asthma | 17 |
| Bronchial Diseases | 16 |
| Lung Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Neoplasms | 10 |
| Respiratory Tract Neoplasms | 10 |
Trials
Showing 26 to 50 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.